Definiens (Booth 6075) is introducing a new image analysis application that allows radiologists to analyze lymph nodes volumetrically and compare them over time. The technology addresses formerly unmet needs by enabling radiologists to rapidly and accurately identify, analyze and track lymph nodes of interest, facilitating earlier detection of the metastatic spread of cancer, the company says. Definiens aims to provide image analysis solutions for cell- and tissue-based assays and medical imaging, such as x-rays, CT and MRI studies.